Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 6
2015 83
2016 90
2017 119
2018 128
2019 125
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

488 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of PARP inhibitor sensitivity and resistance.
D'Andrea AD. D'Andrea AD. DNA Repair (Amst). 2018 Nov;71:172-176. doi: 10.1016/j.dnarep.2018.08.021. Epub 2018 Aug 23. DNA Repair (Amst). 2018. PMID: 30177437 Review.
Poly(ADP-ribose) polymerase activity and inhibition in cancer.
Dulaney C, Marcrom S, Stanley J, Yang ES. Dulaney C, et al. Semin Cell Dev Biol. 2017 Mar;63:144-153. doi: 10.1016/j.semcdb.2017.01.007. Epub 2017 Jan 10. Semin Cell Dev Biol. 2017. PMID: 28087320 Review.
Bochum S, Berger S, Martens UM. Bochum S, et al. Recent Results Cancer Res. 2018;211:217-233. doi: 10.1007/978-3-319-91442-8_15. Recent Results Cancer Res. 2018. PMID: 30069770 Review.
Mitotic functions of poly(ADP-ribose) polymerases.
Slade D. Slade D. Biochem Pharmacol. 2019 Sep;167:33-43. doi: 10.1016/j.bcp.2019.03.028. Epub 2019 Mar 22. Biochem Pharmacol. 2019. PMID: 30910692 Free PMC article. Review.
Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
Chornenkyy Y, Agnihotri S, Yu M, Buczkowicz P, Rakopoulos P, Golbourn B, Garzia L, Siddaway R, Leung S, Rutka JT, Taylor MD, Dirks PB, Hawkins C. Chornenkyy Y, et al. Mol Cancer Ther. 2015 Nov;14(11):2560-8. doi: 10.1158/1535-7163.MCT-15-0282. Epub 2015 Sep 8. Mol Cancer Ther. 2015. PMID: 26351319 Free article.
Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.
Okazaki A, Gameiro PA, Christodoulou D, Laviollette L, Schneider M, Chaves F, Stemmer-Rachamimov A, Yazinski SA, Lee R, Stephanopoulos G, Zou L, Iliopoulos O. Okazaki A, et al. J Clin Invest. 2017 May 1;127(5):1631-1645. doi: 10.1172/JCI87800. Epub 2017 Mar 27. J Clin Invest. 2017. PMID: 28346230 Free PMC article.
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.
Huang X, Motea EA, Moore ZR, Yao J, Dong Y, Chakrabarti G, Kilgore JA, Silvers MA, Patidar PL, Cholka A, Fattah F, Cha Y, Anderson GG, Kusko R, Peyton M, Yan J, Xie XJ, Sarode V, Williams NS, Minna JD, Beg M, Gerber DE, Bey EA, Boothman DA. Huang X, et al. Cancer Cell. 2016 Dec 12;30(6):940-952. doi: 10.1016/j.ccell.2016.11.006. Cancer Cell. 2016. PMID: 27960087 Free PMC article.
488 results
Jump to page